Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine plus buccal midazolam vs intranasal dexmedetomidine plus intravenous propofol for CT sedation in children
ChiCTR2300067469Phase 4Not yet recruiting
- Sponsor
- Fujian Children's Hospital
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in None comparing Dexmedetomidine intranasal + buccal midazolam with Dexmedetomidine intranasal + IV propofol (2 arms). Primary endpoint: success rate of sedation. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
dexmedetomidinemidazolampropofol
Beyond the preview
Go deeper on ChiCTR2300067469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067469.